DEA Pushes Back Against Cannabis Rescheduling
Related Articles
-
White House Announces Cannabis Rescheduling
In an unprecedented but widely anticipated move made by a U.S. president, Biden said today that his administration is rescheduling cannabis.
-
What marijuana reclassification could mean for medical research
The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms, should a proposal to reclassify cannabis as a lower-risk substance be approved, industry experts said. The current classification as a Schedule I substance has limited research into cannabis due to restricted access to cannabis products, regulatory hurdles and funding limitations. Federal research grants are essentially off the table, while...
-
Milwaukee Officials Praise Rescheduling of Cannabis by Biden
New federal policy 'will help reverse longstanding injustices in our legal system.'